Pfizer Defends Bextra After New York Times Report
626420
Pfizer Inc. said on Wednesday that a  report in The New York Times draws "unsubstantiated  conclusions" about the safety of its painkiller Bextra.
513204
The Food and Drug Administration is strengthening warnings about the possible risks of a popular arthritis drug. Bextra, which is made by Pfizer Inc.
479171
NEW YORK  - Pfizer dismissed a report on the safety of its pain reliever Bextra, but the new controversy weighed on the stock price of the US pharmaceutical giant.
122874
Pfizer (PFE) said Friday that it has received new information about the cardiovascular safety of its popular arthritis drug Celebrex, based on an analysis of a long-term cancer trial, but it has no plans to withdraw the drug.
606892
NEW YORK -- Eli Lilly and Co. has downplayed for about 10 years the risks associated with Zyprexa, which treats schizophrenia, The New York Times said on its website yesterday, citing internal documents from the drug maker and e-mail messages of its managers.
57881
The pharmaceutical giant firm Pfizer Inc. fought back Tuesday over a massive lawsuit filed by Nigeria, which alleges the US firm tested an unapproved drug on Nigerian children with meningitis that left 11 youngsters dead and many more badly injured.
247888
AstraZeneca will defend its new prescription drug Exanta before a federal panel today after new questions were raised about the safety and effectiveness of the stroke prevention medication.
225087
NEW YORK - Since Merck&#39;s Vioxx was pulled from the market for increasing the risk of heart attack and stroke in a long-term study, there has been heated debate over whether other, similar medicines, such as Pfizer&#39;s Celebrex and Bextra, carry similar risks
402524
New York - Pfizer, the world&#39;s largest drug maker, is discussing with US regulators whether to add a stronger warning to its Bextra painkiller about rare, serious skin reactions.
304307
Pfizer Inc. on Friday said two small  clinical trials showed heart bypass surgery patients taking  Bextra, an anti-inflammatory in the same class as the recently  withdrawn drug Vioxx, had a higher risk of stroke and heart  attack.
189822
The U.S. Food and Drug  Administration has warned Pfizer Inc.  that television and  print advertisements for its painkillers Celebrex and Bextra  misled consumers, according to a letter made public on  Wednesday.
478882
Pfizer (PFE) said Friday that is has received new information about the cardiovascular safety of its popular arthritis drug Celebrex, based on an analysis of a long-term cancer trial.
420105
Pfizer Inc. will warn doctors that its Bextra painkiller, in the same group of drugs as Merck &amp; Co.&#39;s withdrawn Vioxx, is linked to an elevated risk of blood clots, heart attacks and strokes in cardiac-surgery patients.
323940
First it was antidepressants. Then Vioxx. Now questions have been raised about the safety of yet another drug, the painkiller Bextra, made by Pfizer (PFE ). Is there anything you can do to prevent the unnerving
66408
NEW YORK - On. Dec. 17, the US Food and Drug Administration released a statement relating to Pfizer&#39;s (nyse: PFE - news - people ) Celebrex.
443018
The US Food and Drug Administration yesterday ordered strengthened boxed labels for Pfizer&#39;s Bextra, warning of possible heart and blood clotting problems.
341280
Pfizer Inc.'s painkiller Bextra will  come with a new warning about the possibility of heart attacks  and blood clots in patients who have just had heart bypass  surgery, the U.S. Food and Drug Administration said on  Thursday.